The Food and Drug Administration has approved a drug developed by Carlsbad-based Ionis Pharmaceuticals to treat spinal muscular atrophy in children. The approval of SPINRAZA for treatment of what is a leading genetic cause of death in infants and toddlers came on Friday. The new drug was discovered and developed by Ionis and Biogen, and licensed […]